US equities
|
MU
$947.69
▼-4.18%
META
$767.70
▲+3.33%
NVDA
$225.59
▼-0.32%
SNDK
$1,451.79
▼-2.39%
AAPL
$346.05
▲+1.49%
MSFT
$547.92
▲+1.25%
SPCX
$156.34
▼-4.34%
AMD
$589.05
▼-0.87%
MU
$947.69
▼-4.18%
META
$767.70
▲+3.33%
NVDA
$225.59
▼-0.32%
SNDK
$1,451.79
▼-2.39%
AAPL
$346.05
▲+1.49%
MSFT
$547.92
▲+1.25%
SPCX
$156.34
▼-4.34%
AMD
$589.05
▼-0.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
DatChat, Inc. - Common Stock
(NQ:
DATS
)
2.655
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Aug 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DatChat, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
58 Biggest Movers From Yesterday
↗
August 20, 2021
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
↗
August 16, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares climbed 34.5% to $3.3900 after the company announced plan to expand product portfolio with introduction of Painshield relief for...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
August 17, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of...
Via
Benzinga
24 Stocks Moving in Monday's Pre-Market Session
↗
August 16, 2021
Gainers Enlivex Therapeutics Ltd. (NASDAQ: ENLV) shares rose 26.6% to $12.87 in pre-market trading after the company disclosed that after reviewing its earlier-reported Phase II...
Via
Benzinga
78 Biggest Movers From Friday
↗
August 16, 2021
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >